DTE

30.73

+1.02%↑

IBE

15.705

+0.13%↑

ENGI

17.825

+0.25%↑

ORA

13.685

+1.11%↑

EOAN

15.305

+0.03%↑

DTE

30.73

+1.02%↑

IBE

15.705

+0.13%↑

ENGI

17.825

+0.25%↑

ORA

13.685

+1.11%↑

EOAN

15.305

+0.03%↑

DTE

30.73

+1.02%↑

IBE

15.705

+0.13%↑

ENGI

17.825

+0.25%↑

ORA

13.685

+1.11%↑

EOAN

15.305

+0.03%↑

DTE

30.73

+1.02%↑

IBE

15.705

+0.13%↑

ENGI

17.825

+0.25%↑

ORA

13.685

+1.11%↑

EOAN

15.305

+0.03%↑

DTE

30.73

+1.02%↑

IBE

15.705

+0.13%↑

ENGI

17.825

+0.25%↑

ORA

13.685

+1.11%↑

EOAN

15.305

+0.03%↑

Kodu・Aktsiate loetelu・STRATEC Biomedical AG

STRATEC Biomedical AG

Suletud

26.3 0.19

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

25.7

Max

26.55

Põhinäitajad
By Trading Economics
Sissetulek	11M 12M
Müük	24M 81M
P/E Sektori keskmine	22 24.213
Aktsiakasum	0.09
Dividenditootlus	2.21
Kasumimarginaal	14.203
Töötajad	1,416
EBITDA	16M 23M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+39.89% upside

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	2.21% 3.75%
Järgmine tulemuste avaldamine	7. nov 2025

Turustatistika
By TradingEconomics
Turukapital	6.7M 321M
Eelmine avamishind	26.11
Eelmine sulgemishind	26.3

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

N/A / 24.5 Toetus ja vastupanu

STRATEC Biomedical AG Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

8. juuli 2025, 17:24 UTC

Market Talk

Election, Dollar Seen as Potential Headwinds for Ibovespa -- Market Talk

Võrdlus sarnastega

Hinnamuutus

STRATEC Biomedical AG Prognoos

Hinnasiht

By TipRanks

39.89% tõus

12 kuu keskmine prognoos

Keskmine 37 EUR 39.89%

Kõrge 51 EUR

Madal 30 EUR

Põhineb 4 Wall Streeti analüütiku instrumendi STRATEC Biomedical AG 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

4 ratings

Osta

Hoia

Müü

Põhineb 4 analüütiku instrumendi STRATEC Biomedical AG aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

N/A / 24.5Toetus ja vastupanu

Recent bearish events outweigh bullish events.

All events are bearish.

There are no events.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest STRATEC Biomedical AG

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.